Stephanie Smith
Acute Care · Sevierville, TNNPI 1285307900
Payments from drug & device makers
Across 19 payments — averaging $20.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$87
- Lundbeck LLC$62
- Novo Nordisk$57
- Merz Pharmaceuticals, LLC$25
- Scilex Pharmaceuticals Inc.$24
- Jazz Pharmaceuticals Inc.$23
- plus $118 from 7 others
What the payments were for
- Food & beverage$396100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 2 | $87 |
| Lundbeck LLC | 3 | $62 |
| Novo Nordisk | 4 | $57 |
| Merz Pharmaceuticals, LLC | 1 | $25 |
| Scilex Pharmaceuticals Inc. | 1 | $24 |
| Jazz Pharmaceuticals Inc. | 1 | $23 |
| AstraZeneca | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Seqirus USA Inc | 1 | $16 |
| Boehringer Ingelheim | 1 | $16 |
| Almatica Pharma LLC | 1 | $15 |
| Inogen, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
How this compares
$396 in reported general payments places this provider in the 55th percentile of 738 acute care providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 56 | $642 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $406 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 45 | $391 |
| Cefdinir | 27 | $350 |
| Doxycycline Hyclate | 31 | $279 |
| Ipratropium Bromide | 12 | $277 |
| Prednisone | 147 | $277 |
| Cephalexin | 16 | $272 |
| Azithromycin | 61 | $226 |
| Fluconazole | 25 | $175 |
| Amoxicillin | 43 | $171 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 33 | $139 |
| Ondansetron OdtOndansetron | 15 | $92 |
| Mupirocin | 12 | $80 |
| Ciprofloxacin Hcl | 17 | $78 |
Paid to pharmacies, not to this prescriber.
Other acute care in Sevierville
- Haley HoyNashville$368K
- Anne AlexandrovMemphis$110K
- Stephen MillerKnoxville$108K
- Shannon GraceNashville$57K
- Timothy BallardKnoxville$47K
- Kelsey MartinNashville$42K
- Barbara BrownNashville$36K
- Michelle GoochChattanooga$35K
- Elizabeth DavidsonNashville$33K
- Kelly JacksonMurfreesboro$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.